cblE-type homocystinuria presenting with features of haemolytic-uremic syndrome in the newborn period

JIMD Reports

Volumn 8, Issue , 2013, Pages 57-62

  Palanca, Daniel ^a   Garcia Cazorla, Angels ^a   Ortiz, Jessica ^a   Jou, Cristina ^a   Cusí, Victoria ^a   Suñol, Mariona ^a   Toll, Teresa ^a   Perez, Belén ^b   Ormazabal, Aida ^a   Fowler, Brian ^c   Artuch, Rafael ^a,d  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^d HOSPITAL SANT JOAN DE DÉU   (Spain)

Author keywords

Fatal evolution; Ineffective erythropoiesis; Megaloblastic change; Microangiopathic haemolytic anaemia; Vessel wall thickness

Indexed keywords

EID: 84996459947     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2012_161     Document Type: Chapter

References (23)

1. Chenel C, Wood C, Gourrier E, Zittoun J, Casadevall I, Ogier H (1993) Neonatal hemolytic-uremic syndrome, methylmalonic aciduria and homocystinuria caused by intracellular vitamin B 12 deficiency. Value of etiological diagnosis. Arch Fr Pediatr 50:749–754
2. Fowler B, Whitehouse C, Wenzel F, Wraith JE (1997) Methionine and serine formation in control and mutant human cultured fibroblasts: evidence for methyl trapping and characterization of remethylation defects. Pediatr Res 41:145–151
3. Geraghty MT, Perlman EJ, Martin LS et al (1992) Cobalamin C defect associated with hemolytic-uremic syndrome. J Pediatr 120:934–937
4. Giménez A, Camacho JA, Vila J et al (2008) Síndrome hemolítico-urémico. Revisión de 58 casos. An Pediatr 69:297–303
5. Hajjar KA (1993) Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. J Clin Invest 91:2873–2879
6. Kind T, Levy J, Lee M, Kaicker S, Nicholson JF, Kane SA (2002) Cobalamin C disease presenting as hemolytic-uremic syndrome in the neonatal period. J Pediatr Hematol Oncol 24:327–329
7. Labrune P, Zittoun J, Duvaltier I et al (1999) Haemolytic uraemic syndrome and pulmonary hypertension in a patient with methionine synthase deficiency. Eur J Pediatr 158:734–739
8. Müuller P, Horneff G, Hennermann JB (2007) A rare error of intracellular processing of cobalamine presenting with microcephalus and medaloblastic anemia: a report of 3 children. Klin Pediatr 219:361–367
9. Noris M, Bucchioni S, Galbusera M et al (2005) Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement. J Am Soc Nephrol 16:1177–1183
10. Rodgers GM, Kane WH (1986) Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest 77:1909–1916
11. Rosenblatt DS, Whitehead M (1999) Cobalamin and folate deficiency: acquired and hereditary disorders in children. Semin Hematol 36:19–34
12. Rosenblatt DS, Aspler AL, Shevell MI et al (1997) Clinical heterogeneity and prognosis in combined methylmalonic aciduria and homocystinuria (cblC). J Inherit Metab Dis 20:528–538
13. Russo P, Doyon J, Sonsino E, Ogier H, Saudubray JM (1992) A congenital anomaly of vitamin B12 metabolism: a study of three cases. Hum Pathol 23:504–512
14. Sharma AP, Greenberg CR, Prasad AN, Prasad C (2007) Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder. Pediatr Nephrol 22:2097–2103
15. Skovby F (2003) Disorders of sulfur amino acids. In: Blau N, Duran M, Blaskovics ME, Gibson KB (eds) Physician’s guide to the laboratory diagnosis of metabolic diseases. Springer-Verlag, Berlin, pp 243–260
16. Stamler JS, Osborne JA, Jaraki O et al (1993) Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 91:308–318
17. Tuchman M, Kelly P, Watkins D, Rosenblatt DS (1988) Vitamin B 12-responsive megaloblastic anemia homocystinuria and transient methylmalonic aciduria in Cbl E disease. J Pediatr 113:1052–1056
18. Vilaseca MA, Vilarinho L, Zavadakova P et al (2003) CblE type of homocystinuria: mild clinical phenotype in two patients homo-zygous for a novel mutation in the MTRR gene. J InheritMetab Dis 26:361–369
19. Willard HF, Ambani LM, Hart AC, Mahoney MJ, Rosenberg LE (1976) Rapid prenatal and postnatal detection of inborn errors of propionate, methylmalonate, and cobalamin metabolism: a sensitive assay using cultured cells. Hum Genet 34:277–283
20. Wilson A, Leclerc D, Rosenblatt DS, Gravel RA (1999) Molecular basis for methionine synthase reductase deficiency in patients belonging to the CBLE complementation group of disorders in folate/cobalamin metabolism. Hum Mol Genet 8:2009–2016
21. Zavadakova P, Fowler B, Zeman J, Suormala T, Pristoupilova K, Kozich V (2002) CblE type of homocystinuria due to methionine synthase reductase deficiency: clinical and molecular studies and prenatal diagnosis in two families. J Inherit Metab Dis 25:461–76
22. Zavadakova P, Fowler B, Suormla T et al (2005) CblE type of homocystinuria due to methionine synthase reductase deficiency: functional correction by minigene expression. Hum Mutat 25:239–247
23. Zimmerhackl LB, Besbas N, Jungraithmayr T et al (2006) Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome. Semin Thromb Hemost 32:113–120